The human genome was decoded more than a decade ago. Since then scientists have been successful at identifying genetic mutations in individual patients and tumours. However, using this knowledge to develop improved cancer therapies was hampered because researchers were not able to link the mutations in genes to their corresponding proteins, the targets of most pharmaceutical drugs.
from EUROPA - Syndicated Research News Feed http://ift.tt/1guuI0b
via IFTTT
No comments:
Post a Comment